Literature DB >> 26756677

Proportion of premenopausal and postmenopausal breast cancers attributable to known risk factors: Estimates from the E3N-EPIC cohort.

Laureen Dartois1,2,3, Guy Fagherazzi1,2,3, Laura Baglietto4,5, Marie-Christine Boutron-Ruault1,2,3, Suzette Delaloge6, Sylvie Mesrine1,2,3, Françoise Clavel-Chapelon1,2,3.   

Abstract

Breast cancer is the most frequently diagnosed cancer among women worldwide. Breast cancer risk factors have been widely explored individually; however, little is known about their combined impact. We included 67,634 women from the French E3N prospective cohort, aged 42-72 at baseline. During a 15-year follow-up period, 497 premenopausal and 3,138 postmenopausal invasive breast cancer cases were diagnosed. Population-attributable fractions (PAFs) were used to estimate cases proportions attributable to risk factors under hypothetical scenarios of lowest exposure. We examined overall premenopausal and postmenopausal invasive breast cancers and tumour subtypes (ER status and HER2 expression). Premenopausal breast cancer was not significantly attributable to non-behavioral (61.2%, -15.5 to 91.88%) nor to behavioral (39.9%, -71.0 to 93.9%) factors, contrary to postmenopausal breast cancer (41.9%, 4.5 to 68.7% and 53.5%, 12.8 to 78.7%, respectively). Individually, the highest statistically significant PAFs were obtained in premenopause for birth weight (33.6%, 5.7 to 56.6%) and age at menarche (19.8%, 5.2 to 33.6%) for non-behavioral factors and in postmenopause for history of benign breast diseases (14.9%, 11.6 to 18.0%) and age at menarche (9.7%, 3.9 to 15.5%) for non-behavioral factors and for body shape at menarche (17.1%, 9.7 to 24.3%), use of hormone replacement therapy (14.5%, 9.2 to 19.6%), dietary pattern (10.1%, 2.6 to 17.4%) and alcohol consumption (5.6%, 1.9 to 9.3%) for behavioral factors. These proportions were higher for ER+, HER2- and ER+/HER2- postmenopausal breast cancers. Our data support the hypothesis that in postmenopause, never starting unhealthy behaviors can reduce the number of diagnosed breast cancers.
© 2016 UICC.

Entities:  

Keywords:  attributable fraction; birth weight; breast cancer; cohort study; estrogen receptor; hormone receptor; hormone replacement therapy; postmenopausal women; premenopausal women; risk factors; women

Mesh:

Substances:

Year:  2016        PMID: 26756677     DOI: 10.1002/ijc.29987

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Towards research-tested smartphone applications for preventing breast cancer.

Authors:  Steven S Coughlin; Herpreet Thind; Benyuan Liu; Lt Col Candy Wilson
Journal:  Mhealth       Date:  2016-06-21

2.  Awareness and Misconceptions of Breast Cancer Risk Factors Among Laypersons and Physicians.

Authors:  Jean-François Morère; Jérôme Viguier; Sébastien Couraud; Lysel Brignoli-Guibaudet; Christine Lhomel; Xavier B Pivot; François Eisinger
Journal:  Curr Oncol Rep       Date:  2018-03-05       Impact factor: 5.075

3.  Development of the Physical activity and Your Nutrition for Cancer (PYNC) smartphone app for preventing breast cancer in women.

Authors:  Steven S Coughlin; Gina M Besenyi; Deborah Bowen; Gianluca De Leo
Journal:  Mhealth       Date:  2017-02-15

4.  Insulin resistance and the development of breast cancer in premenopausal women: the Kangbuk Samsung Health Study.

Authors:  Jeesun Lee; Yoosoo Chang; Yejin Kim; Boyoung Park; Seungho Ryu
Journal:  Breast Cancer Res Treat       Date:  2022-01-08       Impact factor: 4.872

5.  Body Mass Index and Mammographic Density in a Multiracial and Multiethnic Population-Based Study.

Authors:  Karen Curtin; Jennifer Anne Doherty; Mollie E Barnard; Tarun Martheswaran; Margaret Van Meter; Saundra S Buys
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

6.  Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women.

Authors:  Oana A Zeleznik; Raji Balasubramanian; Yibai Zhao; Lisa Frueh; Sarah Jeanfavre; Julian Avila-Pacheco; Clary B Clish; Shelley S Tworoger; A Heather Eliassen
Journal:  NPJ Breast Cancer       Date:  2021-05-18

7.  Comparison of methods for estimating the attributable risk in the context of survival analysis.

Authors:  Malamine Gassama; Jacques Bénichou; Laureen Dartois; Anne C M Thiébaut
Journal:  BMC Med Res Methodol       Date:  2017-01-23       Impact factor: 4.615

8.  Estimation of Breast Cancer Incident Cases and Medical Care Costs Attributable to Alcohol Consumption Among Insured Women Aged <45 Years in the U.S.

Authors:  Donatus U Ekwueme; Benjamin T Allaire; William J Parish; Cheryll C Thomas; Diana Poehler; Gery P Guy; Arnie P Aldridge; Sejal R Lahoti; Temeika L Fairley; Justin G Trogdon
Journal:  Am J Prev Med       Date:  2017-09       Impact factor: 5.043

9.  Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors.

Authors:  Kawthar Al-Ajmi; Artitaya Lophatananon; William Ollier; Kenneth R Muir
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

10.  Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies?

Authors:  Martine Bellanger; Nur Zeinomar; Parisa Tehranifar; Mary Beth Terry
Journal:  J Glob Oncol       Date:  2018-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.